syd life AI Wins Osaka Governor's Award at Expo 2025 for Health Innovation
In a remarkable achievement, syd life AI has been awarded the prestigious Osaka Governor's Award during the 'Health and Well-Being' themed week at the 2025 Osaka Kansai Expo. This recognition comes from their participation in the Global Healthcare Challenge (GHeC), a global event that aims to spotlight innovation in the healthcare industry. The accolade is a testament to syd life AI's commitment to leading the world in enhancing individual health outcomes through its advanced AI technology that aims to improve the quality of life.
Founded by Lorena Puica, who also serves as the CEO, syd life AI's mission aligns with Japan's 'Society 5.0' initiative, particularly in promoting health in an aging society and driving urban innovation. The company has seen tangible improvements in quality of life through collaborations with local governments in Japan, notably in Tokyo, where they reported a 23% enhancement in quality of life over 12 months, with an impressive 87% of working professionals using their platform daily.
Upon receiving the award, Lorena Puica expressed her gratitude, emphasizing the honor of receiving recognition at such a significant gathering of global scientific and innovation leaders in Japan's healthcare hub. She commented, "This award not only acknowledges the potential of cutting-edge AI and deep science to create a better future for humanity but also serves as a catalyst propelling our mission to enhance the quality of life across borders, industries, and communities."
syd life AI is set to enter the Japanese market in 2024, having signed an exclusive distribution agreement with Koshidatec, a company with nearly a century-long legacy in innovation and technology. Ryozo Koshida, the executive officer of Koshidatec, voiced his pride in their collaboration with syd life AI, emphasizing their shared vision of delivering evidence-based, AI-driven healthcare solutions nationwide. He affirmed their commitment to providing substantial value to various industries and communities, taking pride in playing a vital role in disseminating this innovative technology.
Currently active in 26 countries, syd life AI has developed an AI platform for global health that utilizes a unique digital twin model, backed by over 1.2 million scientific papers. Their large language model (LLM), with 70 billion parameters, exclusively focuses on improving life quality and showcases the company's capability to lead next-generation healthcare through scientific predictions and data-driven insights.
This recent accolade not only symbolizes syd life AI's dedication but also highlights its potential to become a leader in next-generation healthcare solutions, impacting lives both domestically and internationally. The Global Healthcare Challenge, co-hosted by Japan’s Ministry of Economy, Trade and Industry (METI) and the Japan External Trade Organization (JETRO), gathered key players from the healthcare sector, including corporate leaders and government officials from around the globe, fostering a collaborative environment focused on forward-thinking healthcare solutions.
syd life AI continues to foster academic collaborations with prestigious institutions such as Stanford University, Oxford University, and the University of Cambridge, supported by a world-class scientific advisory committee. Their accolades include being named a 'Future 100 Company' by the UAE Ministry of Economy and receiving a 'Gold Standard' award from the World Intellectual Property Organization (WIPO) for their Life Quality Index™. Moreover, their effective implementation within the UK’s National Health Service saw them earn the 'Seal of Excellence' from the European Commission, highlighting their outstanding contributions to research and innovation.
In 2025, syd life AI will also be recognized by the Saudi Arabian Ministry of Health with an award for 'Outstanding Virtual Health Delivery' in the specialized care category at the MENA Telehealth Awards, reaffirming their status as a global leader in AI-enhanced healthcare.
For inquiries, contact:
Koshidatec Co., Ltd.
Tokyo, Japan
Phone: +81-3-4334-3748
Email: [email protected]
syd life AI, based in London, and founded by Lorena Puica, operates on a mission to revolutionize the health and life quality sector through its innovative AI technologies with a strong emphasis on benefiting individuals and organizations by providing actionable insights based on scientific research and data. They aim to enhance the quality of living extensively for various stakeholders, including governments, insurance companies, industries, educational institutions, and medical organizations.
Founded by Lorena Puica, who also serves as the CEO, syd life AI's mission aligns with Japan's 'Society 5.0' initiative, particularly in promoting health in an aging society and driving urban innovation. The company has seen tangible improvements in quality of life through collaborations with local governments in Japan, notably in Tokyo, where they reported a 23% enhancement in quality of life over 12 months, with an impressive 87% of working professionals using their platform daily.
Upon receiving the award, Lorena Puica expressed her gratitude, emphasizing the honor of receiving recognition at such a significant gathering of global scientific and innovation leaders in Japan's healthcare hub. She commented, "This award not only acknowledges the potential of cutting-edge AI and deep science to create a better future for humanity but also serves as a catalyst propelling our mission to enhance the quality of life across borders, industries, and communities."
syd life AI is set to enter the Japanese market in 2024, having signed an exclusive distribution agreement with Koshidatec, a company with nearly a century-long legacy in innovation and technology. Ryozo Koshida, the executive officer of Koshidatec, voiced his pride in their collaboration with syd life AI, emphasizing their shared vision of delivering evidence-based, AI-driven healthcare solutions nationwide. He affirmed their commitment to providing substantial value to various industries and communities, taking pride in playing a vital role in disseminating this innovative technology.
Currently active in 26 countries, syd life AI has developed an AI platform for global health that utilizes a unique digital twin model, backed by over 1.2 million scientific papers. Their large language model (LLM), with 70 billion parameters, exclusively focuses on improving life quality and showcases the company's capability to lead next-generation healthcare through scientific predictions and data-driven insights.
This recent accolade not only symbolizes syd life AI's dedication but also highlights its potential to become a leader in next-generation healthcare solutions, impacting lives both domestically and internationally. The Global Healthcare Challenge, co-hosted by Japan’s Ministry of Economy, Trade and Industry (METI) and the Japan External Trade Organization (JETRO), gathered key players from the healthcare sector, including corporate leaders and government officials from around the globe, fostering a collaborative environment focused on forward-thinking healthcare solutions.
syd life AI continues to foster academic collaborations with prestigious institutions such as Stanford University, Oxford University, and the University of Cambridge, supported by a world-class scientific advisory committee. Their accolades include being named a 'Future 100 Company' by the UAE Ministry of Economy and receiving a 'Gold Standard' award from the World Intellectual Property Organization (WIPO) for their Life Quality Index™. Moreover, their effective implementation within the UK’s National Health Service saw them earn the 'Seal of Excellence' from the European Commission, highlighting their outstanding contributions to research and innovation.
In 2025, syd life AI will also be recognized by the Saudi Arabian Ministry of Health with an award for 'Outstanding Virtual Health Delivery' in the specialized care category at the MENA Telehealth Awards, reaffirming their status as a global leader in AI-enhanced healthcare.
For inquiries, contact:
Koshidatec Co., Ltd.
Tokyo, Japan
Phone: +81-3-4334-3748
Email: [email protected]
syd life AI, based in London, and founded by Lorena Puica, operates on a mission to revolutionize the health and life quality sector through its innovative AI technologies with a strong emphasis on benefiting individuals and organizations by providing actionable insights based on scientific research and data. They aim to enhance the quality of living extensively for various stakeholders, including governments, insurance companies, industries, educational institutions, and medical organizations.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.